Lowell Blake & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.92M | Buy |
5,770
+3,335
| +137% | +$1.69M | 0.82% | 29 |
|
|
2023
Q2 | $1.27M | Buy |
2,435
+1,185
| +95% | +$618K | 0.37% | 34 |
|
|
2023
Q1 | $720K | Buy |
1,250
+713
| +133% | +$411K | 0.22% | 40 |
|
|
2022
Q4 | $296K | Hold |
537
| – | – | 0.1% | 49 |
|
|
2022
Q3 | $272K | Sell |
537
-1
| -0.2% | -$507 | 0.11% | 47 |
|
|
2022
Q2 | $292K | Sell |
538
-187
| -26% | -$101K | 0.11% | 47 |
|
|
2022
Q1 | $428K | Hold |
725
| – | – | 0.16% | 44 |
|
|
2021
Q4 | $484K | Hold |
725
| – | – | 0.19% | 42 |
|
|
2021
Q3 | $414K | Hold |
725
| – | – | 0.19% | 44 |
|
|
2021
Q2 | $366K | Hold |
725
| – | – | 0.17% | 46 |
|
|
2021
Q1 | $331K | Hold |
725
| – | – | 0.17% | 43 |
|
|
2020
Q4 | $338K | Buy |
725
+25
| +4% | +$11.7K | 0.25% | 36 |
|
|
2020
Q3 | $309K | Hold |
700
| – | – | 0.25% | 42 |
|
|
2020
Q2 | $254K | Buy |
+700
| New | +$254K | 0.24% | 45 |
|
|
2020
Q1 | – | Sell |
-700
| Closed | -$227K | – | 58 |
|
|
2019
Q4 | $227K | Buy |
+700
| New | +$227K | 0.25% | 55 |
|